BeiGene

BeiGene Initiates Phase 3 Trial of Pamiparib as Maintenance Therapy in Patients with Ovarian Cancer
BeiGene Initiates Phase 3 Trial of Pamiparib as Maintenance Therapy in Patients with Ovarian Cancer
CP Wire
BeiGene
pamiparib
ovarian cancer
China
clinical trials
Flag link:
BeiGene Initiates Phase 3 Trial of Pamiparib as Maintenance Therapy in Patients with Ovarian Cancer
BeiGene
pamiparib
ovarian cancer
Flag link:
2 Biotech Stocks Near All-Time Highs: Can They Keep Climbing?
2 Biotech Stocks Near All-Time Highs: Can They Keep Climbing?
Motley Fool
biotech
BeiGene
China
Celgene
AnaptysBio
ANB020
eczema
Flag link:
Boehringer, BeiGene enter manufacturing pact for PD-1 drug
Boehringer, BeiGene enter manufacturing pact for PD-1 drug
Biopharma Dive
Boehringer Ingelheim
BeiGene
tislelizumab
anti-PD-L1
drug manufacturing
Flag link:
Unstoppable growth of Chinese biotechs attracts over $10bn funding
Unstoppable growth of Chinese biotechs attracts over $10bn funding
GoinPharma
China
biotech
Zensun
BeiGene
Chi-Med
Zai Lab
WuXi
Flag link:
Prescribed Reading: I/O is the only game in town
Prescribed Reading: I/O is the only game in town
BioPharma Dive
immuno-oncology
Celgene
BeiGene
Endo International
Opana ER
Novartis
Orkambi
Vertex Pharmaceuticals
Merck
Bristol-Myers Squibb
Roche
Opdivo
Keytruda
Orencia
Flag link:
Celgene joins the PD-1 checkpoint club, bagging BeiGene drug with $413M down and $1B on the table
Celgene joins the PD-1 checkpoint club, bagging BeiGene drug with $413M down and $1B on the table
Endpoints
Celgene
anti-PD-L1
BeiGene
Flag link:
China's BeiGene banks $97M to get its cancer drugs into the clinic
China's BeiGene banks $97M to get its cancer drugs into the clinic
Fierce Biotech
China
BeiGene
Flag link:
China Biotech In Review: Eli Lilly Joins The Big Pharmas Accused Of Bribing In China
China Biotech In Review: Eli Lilly Joins The Big Pharmas Accused Of Bribing In China
Seeking Alpha
Zhejiang Beta Pharma
BeiGene
Eli Lilly
Flag link:
China Biotech In Review: Valeant Pharma Gains Sales Foothold In China With Bausch & Lomb Buy
China Biotech In Review: Valeant Pharma Gains Sales Foothold In China With Bausch & Lomb Buy
Seeking Alpha
Valeant Pharmaceuticals
Bausch & Lomb
BeiGene
Merck Serono
Winteam Pharma
Tongjitang Chinese Medicines
Qiagen
Aslan Pharma
Sinovac Biotech
Vigoo Biological
Flag link:
BeiGene And Merck & Co To Discover Cancer Medicines
BeiGene And Merck & Co To Discover Cancer Medicines
Pharmceutical Insight
BeiGene
Merck
cancer
oncology
Flag link:
China’s Cancer Deaths Spur Merck Investment in Beijing Biotech
China’s Cancer Deaths Spur Merck Investment in Beijing Biotech
Bloomberg
China
Merck
BeiGene
JNJ
biotech
Flag link: